Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012.


Autoria(s): Jimenez-Jorge, S; Mateo, S de; Pozo, F; Casas, I; Garcia Cenoz, M; Castilla, J; Gallardo, V; Perez, E; Vega, T; Rodriguez, C; Quinones, C; Martinez, E; Gimenez, J; Vanrell, JM; Castrillejo, D; Serrano, Mc; Ramos, JM; Larrauri, A
Data(s)

18/01/2013

18/01/2013

22/03/2012

Resumo

We present early estimates of influenza vaccine effectiveness (VE) in the population targeted for vaccination, during 25 December 2011 to 19 February 2012. The adjusted VE was 55% (95% CI: 3 to 79) against any type of influenza virus and 54% (95% CI: 1 to 79) against influenza A(H3N2) virus. This suggests a moderate protective effect of the vaccine in the targeted population in a late influenza epidemic with limited match between vaccine and circulating strains.

Journal Article; Research Support, Non-U.S. Gov't;

Identificador

Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, García Cenoz M, Castilla J, et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill. 2012;17(12):pii=20129.

1560-7917 (Online)

1025-496X (Print)

http://hdl.handle.net/10668/745

22490308

Idioma(s)

en

Publicador

European Centre for Disease Prevention and Control

Relação

Eurosurveillance : Bulletin Européen sur les Maladies Transmissibles = European Communicable Disease Bulletin

http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20129

Direitos

Acceso abierto

Palavras-Chave #Vacunas contra la Influenza #Influenza Vaccines #Efectividad #Medical Subject Headings::Named Groups::Persons::Age Groups::Adult #Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged #Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged::Aged, 80 and over #Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies #Medical Subject Headings::Named Groups::Persons::Age Groups::Child #Medical Subject Headings::Named Groups::Persons::Age Groups::Child::Child, Preschool #Medical Subject Headings::Check Tags::Female #Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans #Medical Subject Headings::Named Groups::Persons::Age Groups::Infant #Medical Subject Headings::Named Groups::Persons::Age Groups::Infant::Infant, Newborn #Medical Subject Headings::Organisms::Viruses::Vertebrate Viruses::RNA Viruses::Orthomyxoviridae::Influenzavirus A::Influenza A virus::Influenza A Virus, H3N2 Subtype #Medical Subject Headings::Chemicals and Drugs::Complex Mixtures::Biological Agents::Vaccines::Viral Vaccines::Influenza Vaccines #Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Orthomyxoviridae Infections::Influenza, Human #Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Models, Theoretical::Models, Statistical::Logistic Models #Medical Subject Headings::Check Tags::Female #Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged #Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Sentinel Surveillance #Medical Subject Headings::Geographicals::Geographic Locations::Europe::Spain #Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunotherapy, Active::Vaccination #Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Young Adult #Medical Subject Headings::Named Groups::Persons::Age Groups::Adolescent
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/published

Artículo